Description: Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Home Page: www.ajantapharma.com
Ajanta House
Mumbai,
400067
India
Phone:
91 22 6606 1000
Officers
| Name | Title |
|---|---|
| Mr. Yogesh Mannalal Agrawal M.B.A | MD & Executive Director |
| Mr. Rajesh Mannalal Agrawal M.B.A | Joint MD & Director |
| Mr. Madhusudan Bhagwandas Agrawal B.Sc | Executive Vice Chairman of the Board |
| Mr. Arvind K. Agrawal B Com, F.C.A, L.L.B | Chief Financial Officer |
| Mr. Gaurang Chinubhai Shah | Senior VP of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer |
| Mr. H. Satish Agrawal M Pharm | President of Tech & Operations |
| Mr. Thampy Jacob | Senior Vice President of HR |
| Mr. H. Nandkishore Agrawal | President of International Business |
| Mr. Pankaj Barbind | Deputy General Manager of Sustainability |
| Mr. Jagdish Dwarkadas Joshi | Executive Vice President |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 41.155 |
| Price-to-Book MRQ: | 9.7322 |
| Price-to-Sales TTM: | 7.9758 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 8073 |